Risk Reduction Solutions for
Pharmaceutical, Life Sciences & Healthcare
Bioquell and COVID-19
Learn more about Bioquell and Ecolabs response, our solutions, the latest news, and key information about the COVID-19 pandemic.
When a multinational biopharmaceutical company in Asia, was looking to introduce a rigorous plan to ensure high-level bio decontamination of their manufacturing facility in the event of contamination, they called on Bioquell. This study overviews how Bioquell’s Rapid Bio Decontamination Service (RBDS) was able to produce a Priority Response Plan (PRP) that enabled swift mobilization of RBDS personnel and equipment and reduced the risk of unforeseen challenges thus minimizing downtime of the manufacturing facility.Download